On February 2, 2026, the U.S. Food and Drug Administration (FDA) published its anticipated compliance program manual, ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA commissioner Marty Makary made the announcement during the 2026 CES trade show The US Food and Drug Administration (FDA) is ...

In a regulatory milestone, the FDA clears AuraWell’s PEMF technology as the first over-the-counter frequency therapy device ...

Regulatory challenges have been even more top of mind than usual given recent upheaval at the FDA. BioSpace spoke to three industry experts about key issues, which include applying new artificial ...

On February 2, 2026, the U.S. Food and Drug Administration’s long-awaited harmonization of the medical device good manufacturing practice ...

At a Glance The FDA reversed its 2022 NMN ban in September 2025, allowing the $500 million ingredient back on the market ...

The Food and Drug Administration (FDA) on Friday conducted coordinated compliance verification visits to major retail ...

The Food and Drug Administration (FDA) announced Thursday it will not enforce federal regulations regarding “false or misleading” material on food labeling in regard to artificial food dyes, giving ...

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

Hims Hers Health Inc (NYSE:HIMS) shares plummeted 12.6% in after-hours trading Friday following a stark warning from federal regulators. The U.S. Food and Drug Administration announced its intent to ...